- Home
- RMTI
as of 12-11-2025 11:50am EST
Rockwell Medical Inc is a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products for dialysis providers. It is a supplier of liquid bicarbonate concentrates, and acid and dry bicarbonate concentrates for dialysis patients in the United States. The company's products include CitraPure citric acid concentrate, RenalPure liquid acid concentrate, and SteriLyte bicarbonate concentrate among others.
| Founded: | 1994 | Country: | United States |
| Employees: | N/A | City: | WIXOM |
| Market Cap: | 35.1M | IPO Year: | 1998 |
| Target Price: | $2.50 | AVG Volume (30 days): | 280.2K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 1 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.17 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.78 - $2.41 | Next Earning Date: | 11-12-2025 |
| Revenue: | $75,577,000 | Revenue Growth: | -23.60% |
| Revenue Growth (this year): | -32.2% | Revenue Growth (next year): | 8.12% |
AI-Powered RMTI Daily Prediction
Machine learning model trained on 25+ technical indicators
AI Recommendation
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
Stock Insider Trading Activity of Rockwell Medical Inc. (RMTI)
Director
Avg Cost/Share
$0.87
Shares
5,079
Total Value
$4,418.73
Owned After
140,372
SEC Form 4
SVP and CFO
Avg Cost/Share
$1.19
Shares
886
Total Value
$1,054.34
Owned After
125,728
SEC Form 4
President and CEO
Avg Cost/Share
$1.19
Shares
6,926
Total Value
$8,241.94
Owned After
330,826
SEC Form 4
SVP and CCO
Avg Cost/Share
$1.19
Shares
2,868
Total Value
$3,412.92
Owned After
125,299
SEC Form 4
SVP, Chief Operating Officer
Avg Cost/Share
$1.19
Shares
2,868
Total Value
$3,412.92
Owned After
135,391
SEC Form 4
| Insider | Ticker | Relationship | Date | Transaction | Avg Cost | Shares | Total Value | Owned After | SEC Forms |
|---|---|---|---|---|---|---|---|---|---|
| COOPER JOHN G | RMTI | Director | Nov 18, 2025 | Sell | $0.87 | 5,079 | $4,418.73 | 140,372 | |
| Neri Jesse | RMTI | SVP and CFO | Oct 1, 2025 | Sell | $1.19 | 886 | $1,054.34 | 125,728 | |
| Strobeck Mark | RMTI | President and CEO | Oct 1, 2025 | Sell | $1.19 | 6,926 | $8,241.94 | 330,826 | |
| Chole Timothy | RMTI | SVP and CCO | Oct 1, 2025 | Sell | $1.19 | 2,868 | $3,412.92 | 125,299 | |
| Hunter Heather | RMTI | SVP, Chief Operating Officer | Oct 1, 2025 | Sell | $1.19 | 2,868 | $3,412.92 | 135,391 |
Compare RMTI vs Leading Stocks
See how RMTI stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "RMTI Rockwell Medical Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.